Lineage commitment, differentiation, and self-renewal of hematopoietic stem cells are likely to involve specific changes in patterns of gene expression under the control of regulatory transcription factors. These altered patterns of gene expression are important, not only in producing cell-type specific proteins, but also in determining if, and when, cells continue to proliferative or to exit the cell cycle. The Myc transcription factor has been shown to play an important role in this decision in hematopoietic cells. Earlier work has demonstrated that Myc functions as part of a network of interacting proteins which include Myc's obligate dimerization partner, Max, as well as other Max interacting proteins, including the Mad family of transcriptional repressors. The Myc network is known to be involved in proliferation, differentiation, apoptosis and neoplasia. Work during the previous grant period has pointed to a role for Mad in hematopoietic cell differentiation and has led to a better understanding of the function of Myc. In this application we propose to extend these studies in order to elucidate the function of these proteins in hematopoietic cells.
In Specific Aims 1 and 2 we plan to employ targeted deletions, as well transgenic in hematopoietic cells.
In Specific Aims 1 and 2 we plan to employ targeted deletions, as well transgenic expression, or murine mad family genes to study hematopoiesis in vivo.
In Aim 1 we propose to analyze the role of Myc and Mad transcriptional activities in hematopoietic development by examining their activities in the context of the known signaling pathways that control lymphopoiesis. The results of these studies will be used in Aim 2 to guide experiments on the role of Mad in the regulation of hematopoietic stem cell pool size, growth factor sensitivity, and lineage commitment.
In Specific Aim 3 we will use oligonucleotide microarray analysis to identify genes differentially regulated by Myc and Mad in hematopoietic cells. Because Myc and Mad proteins appear to regulate transcription through alterations in histone acetylation, this work will help correlate hematopoietic differentiation with specific changes in gene expression and chromatin structure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL054881-07
Application #
6494848
Study Section
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2001
Total Cost
$209,389
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Varnum-Finney, Barbara; Dallas, Mari H; Kato, Keizo et al. (2008) Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus. Blood 111:2615-20
Piasecki, Julia C; Beagles, Karen; Beard, Brian C et al. (2008) Induction of transgene-specific cytotoxic T lymphocyte responses after transplantation of gene-modified CD34+ cells despite nonablative immunosuppressive conditioning. Hum Gene Ther 19:103-7
Si, Jutong; Mueller, LeMoyne; Schuler, Aaron et al. (2007) The retinoic acid receptor/CaMKII interaction: pharmacologic inhibition of CaMKII enhances the differentiation of myeloid leukemia cells. Blood Cells Mol Dis 39:307-15
Aoyama, Keisuke; Delaney, Colleen; Varnum-Finney, Barbara et al. (2007) The interaction of the Wnt and Notch pathways modulates natural killer versus T cell differentiation. Stem Cells 25:2488-97
Dallas, Mari H; Varnum-Finney, Barbara; Martin, Paul J et al. (2007) Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1. Blood 109:3579-87
Shepherd, Bryan E; Kiem, Hans-Peter; Lansdorp, Peter M et al. (2007) Hematopoietic stem-cell behavior in nonhuman primates. Blood 110:1806-13
Gerull, Sabine; Beard, Brian C; Peterson, Laura J et al. (2007) In vivo selection and chemoprotection after drug resistance gene therapy in a nonmyeloablative allogeneic transplantation setting in dogs. Hum Gene Ther 18:451-6
Jung, Chul Won; Beard, Brian C; Morris, Julia C et al. (2007) Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates. Exp Hematol 35:1132-9
Si, Jutong; Mueller, LeMoyne; Collins, Steven J (2007) CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. J Clin Invest 117:1412-21
Neff, Tobias; Gerull, Sabine; Peterson, Laura J et al. (2007) Improved short-term engraftment of lentivirally versus gammaretrovirally transduced allogeneic canine repopulating cells. J Gene Med 9:357-61

Showing the most recent 10 out of 94 publications